Skip to search formSkip to main contentSkip to account menu

Tolazamide

Known as: N-(P-Toluenesulfonyl)-n'-hexamethyleniminourea, Tolazamidum, 1-(hexahydro-1-Azepinyl)-3-P-tolylsulfonylurea 
An intermediate-acting, first-generation sulfonylurea with hypoglycemic activity. Tolazamide is converted into five major metabolites that are… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
1996
Highly Cited
1996
OBJECTIVE: To compare the risk of serious hypoglycemia associated with the use of individual sulfonylureas in older people. 
Highly Cited
1992
Highly Cited
1992
IN 1984, Congress enacted a new law that greatly affected the economics of the pharmaceutical industry in the United States. It… 
Highly Cited
1988
Highly Cited
1988
Highly Cited
1986
Highly Cited
1986
To determine whether sulfonylureas and exogenous insulin have different effects on insulin action, we studied eight patients with… 
Review
1981
Review
1981
Highly Cited
1980
Highly Cited
1980
1956
1956
Summary Oral administration of 100 mg 1-3-butyl-p-tolylsulfonylurea per kg body weight to normal rats results in a marked…